Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3012791012 | Janus kinase inhibitor | en | Synonym | Active | Case sensitive | SNOMED CT core |
| 3520758018 | Substance with Janus kinase inhibitor mechanism of action (substance) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 3520928016 | Substance with Janus kinase inhibitor mechanism of action | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Janus kinase inhibitor | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Janus kinase inhibitor | Has disposition | Janus kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fedratinib | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Upadacitinib | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Fedratinib hydrochloride | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Upadacitinib hemihydrate | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Tofacitinib | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Ruxolitinib | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Janus kinase inhibitor-containing product | Has active ingredient | True | Janus kinase inhibitor | Inferred relationship | Some | 1 |
| Baricitinib | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Tofacitinib citrate | Is a | True | Janus kinase inhibitor | Inferred relationship | Some | |
| Ruxolitinib phosphate | Is a | True | Janus kinase inhibitor | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR